IGF1 and Insulin resistance: The transition period is marked by a reduction in insulin levels and tissue responsiveness of this hormone, with an increase in growth hormone (GH) levels and a reduction in IGF-1, characterizing uncoupling of the somatotropic axis and peripheral insulin resistance (Figure 1) [12,13,14,15].